Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Phenytoin 30mg/5ml oral suspension
0408010Z0AAAAAA
|
Phenytoin | Phenytoin | Central Nervous System | 3,671 |
|
Phenytoin 50mg chewable tablets
0408010Z0AAACAC
|
Phenytoin | Phenytoin | Central Nervous System | 369 |
|
Phenytoin 90mg/5ml oral suspension
0408010Z0AAALAL
|
Phenytoin | Phenytoin | Central Nervous System | 148 |
|
Phenytoin 90mg/5ml oral solution
0408010Z0AABIBI
|
Phenytoin | Phenytoin | Central Nervous System | 13 |
|
Phenytoin 300mg/5ml oral liquid
0408010Z0AABHBH
|
Phenytoin | Phenytoin | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.